carbostyril has been researched along with Impotence in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (83.33) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mari, Jde J; Moreira, HC; Nunes, LV; Nunes, SO; Razzouk, D | 1 |
| Bhattacharjee, S; Clancy, J; Guan, J; Haynes-Johnson, D; Jiang, W; John, TM; Kraft, P; Macielag, MJ; Qiu, Y; Sui, Z; Zhang, S | 1 |
| Bhattacharjee, S; Clancy, J; Craig, E; Fiordeliso, JJ; Guan, J; Haynes-Johnson, D; Jiang, W; John, TM; Kraft, P; Lanter, JC; Macielag, MJ; Qiu, Y; Sui, Z; Walsh, SP | 1 |
| Boissard, CG; Cook, D; Ding, M; Dworetzky, SI; Fan, W; Flint, K; Goggins, GD; Gribkoff, VK; Hewawasam, P; Lodge, NJ; Myers, RA; Starrett, JE | 1 |
| Bhattacharjee, S; Guan, J; Haynes-Johnson, D; Jiang, W; John, TM; Kraft, P; Lundeen, S; Macielag, MJ; Qiu, Y; Sui, Z; Zhang, S | 1 |
| Aitchison, KJ; McAllister, V; Mir, A; O'Keane, V; Shivakumar, K; Williamson, RJ | 1 |
1 review(s) available for carbostyril and Impotence
| Article | Year |
|---|---|
Strategies for the treatment of antipsychotic-induced sexual dysfunction and/or hyperprolactinemia among patients of the schizophrenia spectrum: a review.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Drug Substitution; Drug Therapy, Combination; Erectile Dysfunction; Female; Humans; Hyperprolactinemia; Male; Piperazines; Psychotic Disorders; Purines; Quinolones; Schizophrenia; Schizophrenic Psychology; Sexual Dysfunction, Physiological; Sildenafil Citrate; Sulfones; Vasodilator Agents | 2012 |
5 other study(ies) available for carbostyril and Impotence
| Article | Year |
|---|---|
Pyrimidinylpyrroloquinolones as highly potent and selective PDE5 inhibitors for treatment of erectile dysfunction.
Topics: 3',5'-Cyclic-GMP Phosphodiesterases; Administration, Oral; Animals; Biological Availability; Cyclic Nucleotide Phosphodiesterases, Type 5; Dogs; Enzyme Inhibitors; Erectile Dysfunction; Male; Quinolones; Rats; Structure-Activity Relationship | 2002 |
Furoyl and benzofuroyl pyrroloquinolones as potent and selective PDE5 inhibitors for treatment of erectile dysfunction.
Topics: 3',5'-Cyclic-GMP Phosphodiesterases; Animals; Biological Availability; Cell Line; Cyclic GMP; Cyclic Nucleotide Phosphodiesterases, Type 5; Dogs; Erectile Dysfunction; Furans; Isoenzymes; Male; Penile Erection; Quinolones; Rats; Structure-Activity Relationship | 2003 |
4-Aryl-3-(hydroxyalkyl)quinolin-2-ones: novel maxi-K channel opening relaxants of corporal smooth muscle targeted for erectile dysfunction.
Topics: Animals; Blood Pressure; Electric Stimulation; Erectile Dysfunction; In Vitro Techniques; Large-Conductance Calcium-Activated Potassium Channels; Male; Muscle Relaxation; Muscle, Smooth; Penile Erection; Penis; Potassium Channels, Calcium-Activated; Pressure; Quinolones; Rabbits; Rats; Rats, Inbred F344; Structure-Activity Relationship | 2003 |
Pyrroloquinolone PDE5 inhibitors with improved pharmaceutical profiles for clinical studies on erectile dysfunction.
Topics: 3',5'-Cyclic-GMP Phosphodiesterases; Animals; Biological Availability; Blood Pressure; Cell Line; Cyclic GMP; Cyclic Nucleotide Phosphodiesterases, Type 5; Dogs; Electric Stimulation; Erectile Dysfunction; Macaca mulatta; Male; Penis; Pyrroles; Quinolones; Rats; Rats, Sprague-Dawley; Solubility; Stereoisomerism; Structure-Activity Relationship | 2005 |
Change in sexual dysfunction with aripiprazole: a switching or add-on study.
Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Aripiprazole; Ejaculation; Erectile Dysfunction; Female; Humans; Hyperprolactinemia; Libido; Male; Menstruation Disturbances; Middle Aged; Piperazines; Psychiatric Status Rating Scales; Psychotic Disorders; Quinolones; Sex Characteristics; Sexual Dysfunction, Physiological; Surveys and Questionnaires | 2008 |